Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that ...
Algorithms give computers step-by-step instructions to complete tasks accurately.Good algorithms improve software speed, efficiency, and overall ...
A research team at POSTECH led by Professor Wook-Shin Han of the Department of Computer Science and Engineering and the ...
The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...
Anthropic PBC has sounded the alarm on the rapid pace of artificial intelligence development and is calling on the world’s ...
Abstract: In the current era, vast amounts of data are readily available, particularly in the form of multi-structured data such as sequences, trees, and graphs. Analyzing these diverse data types ...
Boltz-2 is an open-source biomolecular model achieving near-FEP accuracy with 1000x faster predictions for structure and binding affinity. MIT and Recursion have released Boltz-2, the first ...
Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse events In comparison to placebo, treatment with REC-994 400 mg showed ...
SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced top-line results of ...
The process of developing novel medicines is notoriously complicated, expensive, and long. Though you might think it's getting faster and cheaper thanks to technological breakthroughs, the opposite is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results